Tag: VIK
Boehringer Ingelheim, partner of VIK, the application to support patients with Idiopathic Pulmonary Fibrosis (IPF)
Paris, January 17, 2022 – Developed by the start-up Wefight with the institutional support of Boehringer Ingelheim, the Vik FPI application is the first solution designed to support and inform…